USPSTF TEST PAPER COMPLETE QUESTIONS AND ACCURATE ANSWERS PREMIUM REVIEW SHEET

USPSTF TEST PAPER COMPLETE
QUESTIONS AND ACCURATE ANSWERS
PREMIUM REVIEW SHEET

●● Abdominal Aortic Aneurysm: Screening: men aged 65 to 75 years
who have ever smoked
Answer: The USPSTF recommends 1-time screening for abdominal
aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75
years who have ever smoked. B December 2019 *


●● Anxiety Disorders in Adults: Screening: adults 64 years or younger,
including pregnant and postpartum persons
Answer: The USPSTF recommends screening for anxiety disorders in
adults, including pregnant and postpartum persons. B June 2023


●● Anxiety in Children and Adolescents: Screening: children and
adolescents aged 8 to 18 years
Answer: The USPSTF recommends screening for anxiety in children
and adolescents aged 8 to 18 years. B October 2022


●● Aspirin Use to Prevent Preeclampsia and Related Morbidity and
Mortality: Preventive Medication: pregnant persons at high risk for
preeclampsia

,Answer: The USPSTF recommends the use of low-dose aspirin (81
mg/day) as preventive medication after 12 weeks of gestation in persons
who are at high risk for preeclampsia. See the Practice Considerations
section for information on high risk and aspirin dose. B September 2021
*


●● Asymptomatic Bacteriuria in Adults: Screening: pregnant persons
Answer: The USPSTF recommends screening for asymptomatic
bacteriuria using urine culture in pregnant persons. B September 2019 *


●● BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and
Genetic Testing: women with a personal or family history of breast,
ovarian, tubal, or peritoneal cancer or an ancestry associated with
brca1/2 gene mutation
Answer: The USPSTF recommends that primary care clinicians assess
women with a personal or family history of breast, ovarian, tubal, or
peritoneal cancer or who have an ancestry associated with breast cancer
susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate
brief familial risk assessment tool. Women with a positive result on the
risk assessment tool should receive genetic counseling and, if indicated
after counseling, genetic testing. B August 2019 *


●● Breast Cancer: Medication Use to Reduce Risk: women at increased
risk for breast cancer aged 35 years or older
Answer: The USPSTF recommends that clinicians offer to prescribe
risk-reducing medications, such as tamoxifen, raloxifene, or aromatase

, inhibitors, to women who are at increased risk for breast cancer and at
low risk for adverse medication effects. B September 2019 *


●● Breast Cancer: Screening: women aged 40 to 74 years
Answer: The USPSTF recommends biennial screening mammography
for women aged 40 to 74 years. † B April 2024 *


●● Breastfeeding: Primary Care Behavioral Counseling Interventions:
pregnant and postpartum women
Answer: The USPSTF recommends providing interventions or referrals,
during pregnancy and after birth, to support breastfeeding. B April 2025
*


●● Cervical Cancer: Screening: women aged 21 to 65 years
Answer: The USPSTF recommends screening for cervical cancer every
3 years with cervical cytology alone in women aged 21 to 29 years. For
women aged 30 to 65 years, the USPSTF recommends screening every 3
years with cervical cytology alone, every 5 years with high-risk human
papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV
testing in combination with cytology (cotesting). See the Clinical
Considerations section for the relative benefits and harms of alternative
screening strategies for women 21 years or older. A August 2018 *


●● Chlamydia and Gonorrhea: Screening: sexually active women,
including pregnant persons